化学抗原受体能够通过快速杀死感染细胞,更好地控制HIV复制

Yuqi Zhou1, Julie Jadlowsky1, Caitlin Baiduc1

  • 1Department of Microbiology and Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

PLoS pathogens
|December 15, 2023
PubMed
概括

工程T细胞显示出对治愈艾滋病毒的希望. 化学抗原受体 (CAR) T 细胞在控制HIV复制方面优于T 细胞受体 (TCRs),这是由于更快的目标识别和杀死.